Stem Neurological Disease

The Problem: Multiple Sclerosis (MS) is a chronic and unpredictable central nervous system disorder that affects the brain and spinal cord. It is an autoimmune disease, which means the immune system mistakenly attacks healthy parts if the body as if they were foreign and dangerous. The fact that our central nervous system has a limited capacity for regeneration is one of the main reasons for progressive neurological decline in chronic diseases such as MS, ALS (Amyotrophic Lateral Disease), Parkinson’s disease, Alzheimer’s disease as well as brain and spinal trauma and stroke.

There is no cure, but there is hope. New research is showing positive results.

The Solution: Stem cells from adult bone marrow effectively suppress inflammation. Research at Hadassah Hospital in Jerusalem is showing that stem cells not only protect damaged neurons and prevent cell death, but also repair/regenerate damaged cells. These features make stem cells potential candidates for therapies in inflammatory and degenerative diseases.

-
The Research: In 2015, Hadassah started a double blind, randomised, phase IIb efficacy clinical trial in MS. It is the first in the world to use the intrathecal (spinal) method. The aim of this trial is to assess and improve the efficacy of stem cell transplantation and define the optimal conditions of their administration (one vs multiple injections; intrathecal vs intravenous injection) in MS patients. To assess efficacy, Hadassah intends to use the most advanced technologies for identifying regeneration of the central nervous system and myelin.

The trial, under the direction of Professor Dimitrios Karussis, head of the Multiple Sclerosis Center at Hadassah Hospital’s Department of Neurology, has 48 patients in a double blind, placebo-controlled study. The novel concept of injecting stem cells directly into the spinal fluid is aimed at getting the cells to circulate to the various damaged areas of the central nervous system.

The Results: In MS patients, there is a clear trend towards neurological improvement, including substantial improvement in motor function. These findings demonstrate for the first time that intrathecal injection of stem cells in patients with MS is a clinically feasible and relatively safe procedure that provides significant clinical benefits.

In the latest study in 2016, 87% of patients responded positively to their treatment, with no serious side effects observed to date.

Disability was stabilised during the first six months following the treatment.
Results indicated a halt of the progression of the disease.
Disability showed a clear trend for improvement including substantial increases in motor function.

Hadassah Hospital has the advantage of more than ten years experience with the clinical application of stem cells in neurological diseases and uses its unique protocol of direct injection into the spinal fluid. In addition, Hadassah’s novel and patented type of modified (“neutralised”) stem cells will be used in future trials.

The exciting findings observed so far in Hadassah’s stem cell research in MS patients may change the face of neurology. Promising results in MS are likely to have application for treatment in other cases of brain degeneration, such as ALS, Alzheimers, Parkinson’s, stroke and spinal trauma. Hadassah has conducted research into stem cell transplantation in two trials with MS patients and a smaller study with ALS patients. The findings in both groups have been encouraging, with no major side effects being recorded.

The Trial: The trial, under the direction of Professor Karussis, has 48 patients in a double blind, placebo-controlled study. The novel concept of injecting stem cells directly into the spinal ﬂuid is aimed at getting the cells to circulate to the various damaged areas of the central nervous system.

“I believe we are in the early stages of something new and revolutionary with this harvested stem cell infusion therapy.

I am confident that within the next three to five years, we may provide a treatment to patients that can stop the progression of these diseases and induce some kind of recovery. Preliminary results of our trial have seen wheelchair-bound patients getting back on their own two feet.”

Prof Dimitrios Karussis, Head, Multiple Sclerosis Center, Department of Neurology, Hadassah Hospital

Case Study: Mark Lewis

Mark is one of the UK’s most successful media lawyers. He was instrumental in bringing the case against News of the World, as a result of the 2011 phone hacking scandal. Mark was diagnosed with MS when he was 24. By 2016 he was using a wheelchair and mobility scooter. and had given up driving.

He says, I wish I could say to you I never feel sorry for myself but I always feel sorry for myself – I have moments of absolute depression. My health had gone rapidly into a downward spiral. I heard about the medical trial in Hadassah. As a lawyer, all my working life I’d done trials, often very high profile, with a philosophy that every case at trial is 50/50. Either you win or you lose. This was my most important trial. It was not just about cosmetic appearance but whether I would be able to work. My memory is unaffected, but my body was failing.

The research at Hadassah is miraculous. I joke that if there is a place where a miracle could happen, then Jerusalem is a suitable candidate. Within two hours of my treatment, I could walk again without a stick and the pain that showed the onset of MS when I was 28 disappeared. 28 years, more than half my life, and it just disappeared within two hours of the transfusion. I honestly feel that the treatment is not just life changing, but as my wife Mandy says “life giving”. It is a new lease of life.

Case Study: Malia Litman

Malia says, In 1999, I was too young, too busy, and I felt too good to have multiple sclerosis. I had been a nurse, so I knew that people with MS are in wheelchairs. But I did have multiple sclerosis. There was no explanation. There was no cure.

As time passed my symptoms got worse. The turning point came because of a fall in gravel at my daughter’s school. I had fallen before, but this fall was not only the result of balance issues, but sheer weakness and fatigue.

In 2013 I fell in the middle of the night and broke my leg. We installed handicapped railings in the bathroom. Muscles that I had previously used for walking had atrophied. I knew it was time to get more aggressive with my MS treatment. I researched the internet. Of all the physicians in the world, Prof Karussis’ Stem Cell research at Hadassah Hospital in Jerusalem seemed the most promising. His scientific method was sound. His results were exciting, and verifiable. Side effects seemed unlikely since he used the patient’s own stem cells taken through bone marrow extraction.

After my first stem cell infusion, I realised immediate benefits. In less than 24 hours my speech improved. I had enhanced strength in my weakest leg, and improvement in fine motor skills. The greatest change was a profound difference in fatigue.

I may never walk without assistance, but I am a realist who believes in miracles. Hadassah Hospital and Prof Karussis have made my dreams become a reality. I will forever be indebted to them for giving me the miracle of hope.

Latest

Study Links Blood Glucose Levels to Risk For Serious Case of COVID-19

Nondiabetic individuals with high blood glucose levels after fasting who contract COVID-19 are at higher risk for developing a serious case of the disease, according to a collaborative study conducted by the Jerusalem College of Technology, Hadassah Medical Organization, Hebrew University-Hadassah Braun School of Public Health and Community Medicine and the Israeli health fund Meuhedet.
Israeli Study of Lazy Eye Reveals Public Health Blindspot

In the largest population-based study to evaluate the prevalence of lazy eye in teenagers, a team of Israeli researchers found that among 1½ million teens aged 16½ to 18 years old, one percent had a lazy eye. The prevalence was higher among those with lower socioeconomic status and lower scores on cognitive function tests.
Educating to Good Health: Ethiopian Students Embolden Israel's Health

Hadassah Australia’s commitment to assist young Ethiopian-Israelis enter Israel’s health system was ‘front and centre’ with the graduation of the first cohort of twelve Achotenu students in June. [Read more]
Shana Tova

As we approach Rosh Hashanah (New Year) and Yom Kippur (Day of Atonement), there has never been a more important time to reach out to family and friends. We wish them l’shana tovah u’metukah, a good and sweet year, and g’mar chatima tovah, to acknowledge the traditional belief that a person’s fate for the coming year is written on Rosh Hashanah and sealed on Yom Kippur. [Read more]

Bat Ami Center

Bat Ami Center for Victims of Sexual Abuse was established in 2009. Open 24 hours a day, the primary goal of the treatment at the Center is to return control to the victim.
Healing and Environmental Garden

Hadassah’s Healing and Environmental Garden on the slopes of Mt Scopus is an example of how lives can change for the better.
Capital Works Rehab Centre

Stay tuned! More information coming soon.

Shana Tova

As we approach Rosh Hashanah (New Year) and Yom Kippur (Day of Atonement), there has never been a more important time to reach out to family and friends. We wish them l’shana tovah u’metukah, a good and sweet year, and g’mar chatima tovah, to acknowledge the traditional belief that a person’s fate for the coming year is written on Rosh Hashanah and sealed on Yom Kippur. [Read more]
Starting again at age 70: surgeon joins Hadassah’s neurosurgery team

At age 70, many professionals are thinking about settling down. When Prof Andrew Kaye moved from Australia to Israel at age 70, he became Hadassah's director of Neurosurgery Resident Training, and he hasn't looked back.
New successful Aortic Aneurysm treatment breakthrough

A senior interventional cardiologist at Hadassah Medical Organization, Dr. Planer has played a key role in developing a new exploratory method of treating aortic arch aneurysms, a life-threatening condition with limited therapeutic options.
Staff
Two problems, one solution

Hadassah-Achotenu’s Nursing Scholarship in Health are closing Israel’s nursing gap and providing a career path for disadvantaged Ethiopian-Israelis.
Medical Scholarships and fellowships

Medical fellowships are a key aspect of Hadassah's mission to promote treatment of diseases and up-skilling of medical professionals.
Hadassah — More Than a Hospital

Consistent with its philosophy of equal treatment and employment opportunities, the doors to Hadassah Hospital are open to everyone, irrespective of race, religion, nationality, gender or financial status, be they staff, patients or their families.
Early childhood development - Goshen

The Goshen Project was initiated by Hadassah Australia and is based on the pioneering work of Professor Frank Oberklaid, which seeks to address the treatment of chronic illnesses among children as well as developmental and behavioural problems.
Hadassah-Achotenu Ethiopian University Scholarships in Health

The Ethiopian-Israeli Scholarship program plays a vital role in ensuring the future of nursing and occupational therapy professions in Israel. Hadassah is facilitating the training of nurses and OTs from underprivileged Ethiopian communities and ensuring ethnic and cultural representation in their fields.
Trauma and Crisis Intervention

The Jerusalem Crisis Intervention Center (JCIC) is saving young lives in a city with the highest rate of youth trauma in Jerusalem, where many of the young clients who come to the JCIC have a time-critical need.